Sturk A - Search Results

1

A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency.

Vreken P, Niessen RW, Peters M, Schaap MC, Zuithoff-Rijntjes JG, Sturk A. Vreken P, et al. Among authors: sturk a. Thromb Haemost. 1995 Aug;74(2):584-9. Thromb Haemost. 1995. PMID: 8584988

2

The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells.

Niessen RW, Pfaffendorf BA, Sturk A, Lamping RJ, Schaap MC, Hack CE, Peters M. Niessen RW, et al. Among authors: sturk a. Thromb Haemost. 1995 Aug;74(2):686-92. Thromb Haemost. 1995. PMID: 8585007

3

Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.

Onland W, Böing AN, Meijer AB, Schaap MC, Nieuwland R, Haasnoot K, Sturk A, Peters M. Onland W, et al. Among authors: sturk a. Haemophilia. 2005 Sep;11(5):539-47. doi: 10.1111/j.1365-2516.2005.01137.x. Haemophilia. 2005. PMID: 16128900

4

Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.

Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ, ten Cate JW. Fijnvandraat K, et al. Among authors: sturk a. Thromb Haemost. 1995 Jan;73(1):15-20. Thromb Haemost. 1995. PMID: 7740486

5

Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons.

Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB Jr, de Vijlder JJ, ten Cate JW, Hack CE, Sturk A. Niessen RW, et al. Among authors: sturk a. Thromb Haemost. 1997 Sep;78(3):1088-92. Thromb Haemost. 1997. PMID: 9308758

6

Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency.

Gómez García EB, Poort SR, Stibbe J, Sturk A, Schaap MC, Kappers M, Bertina RM. Gómez García EB, et al. Among authors: sturk a. Br J Haematol. 2001 Feb;112(2):513-8. doi: 10.1046/j.1365-2141.2001.02577.x. Br J Haematol. 2001. PMID: 11167856 Free article.

7

Sequence characterization of a sheep cDNA for antithrombin III.

Niessen RW, Sturk A, Hordijk PL, Michiels F, Peters M. Niessen RW, et al. Among authors: sturk a. Biochim Biophys Acta. 1992 Dec 29;1171(2):207-10. doi: 10.1016/0167-4781(92)90123-h. Biochim Biophys Acta. 1992. PMID: 1482684

8

Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids.

Sturk A, Schaap MC, Prins A, ten Cate JW, van den Bosch H. Sturk A, et al. Biochim Biophys Acta. 1989 Dec 8;993(2-3):148-56. doi: 10.1016/0304-4165(89)90157-8. Biochim Biophys Acta. 1989. PMID: 2512985

9

Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Niessen RW, Rezaee F, Reitsma PH, Peters M, de Vijlder JJ, Sturk A. Niessen RW, et al. Among authors: sturk a. Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):263-70. doi: 10.1042/bj3180263. Biochem J. 1996. PMID: 8761481 Free PMC article.

10

DNA length polymorphism present in the antithrombin III promoter region does not influence plasma antithrombin III activity levels.

Niessen RW, Lamping RJ, Sturk A, Peters M. Niessen RW, et al. Among authors: sturk a. Thromb Haemost. 1996 Feb;75(2):376-7. Thromb Haemost. 1996. PMID: 8815596 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page